🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
May 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — May 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1902)
All (1902)
Buys (248)
Sells (1654)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
PULSE BIOSCIENCES, INC.
(PLSE)
LAVIOLETTE PAUL A
— Director
May 11, 2026
Purchase
Shares
15,000
Price
$19.69
Total Value
$295.35K
Shares Held After
15,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alphatec Holdings, Inc.
(ATEC)
Valentine Keith
— Director
May 11, 2026
Purchase
Shares
35,000
Price
$7.00
Total Value
$245.00K
Shares Held After
232,271
% of Holdings
15.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sionna Therapeutics, Inc.
(SION)
Thompson Peter A.
— Director
May 11, 2026
Sale
Shares
184,639
Price
$46.22
Total Value
$8.53M
Shares Held After
2,671,822
% of Holdings
6.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Ridloff Elena
— Director
May 11, 2026
Sale
Shares
3,000
Price
$87.00
Total Value
$261.00K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aclarion, Inc.
(ACON)
Ness Brent
— Director
May 11, 2026
Purchase
Shares
6,289
Price
$3.18
Total Value
$20.00K
Shares Held After
6,300
% of Holdings
99.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VIVOS INC
(RDGL)
Korenko Michael K
— Director
May 11, 2026
Purchase
Shares
150,000
Price
$0.06
Total Value
$9.27K
Shares Held After
11,085,090
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
May 8, 2026
Sale
Shares
1,150
Price
$210.34
Total Value
$241.90K
Shares Held After
252,502
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
May 8, 2026
Sale
Shares
200
Price
$209.57
Total Value
$41.91K
Shares Held After
253,652
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
May 8, 2026
Sale
Shares
700
Price
$208.13
Total Value
$145.69K
Shares Held After
253,852
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
May 8, 2026
Sale
Shares
900
Price
$207.24
Total Value
$186.52K
Shares Held After
254,552
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
May 8, 2026
Sale
Shares
200
Price
$205.43
Total Value
$41.09K
Shares Held After
255,452
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InspireMD, Inc.
(NSPR)
Stuka Paul
— Director
May 8, 2026
Purchase
Shares
65,626
Price
$1.16
Total Value
$76.13K
Shares Held After
622,871
% of Holdings
10.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Werewolf Therapeutics, Inc.
(HOWL)
EVNIN LUKE
— Director
May 8, 2026
Sale
Shares
305,741
Price
$0.70
Total Value
$214.02K
Shares Held After
1,273,008
% of Holdings
19.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Liquidia Corp
(LQDA)
JEFFS ROGER
— Director
May 8, 2026
Sale
Shares
25,000
Price
$42.14
Total Value
$1.05M
Shares Held After
1,323,095
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Werewolf Therapeutics, Inc.
(HOWL)
RA CAPITAL MANAGEMENT, L.P.
— 10% Owner
May 8, 2026
Sale
Shares
25,012
Price
$0.71
Total Value
$17.76K
Shares Held After
418,813
% of Holdings
5.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Werewolf Therapeutics, Inc.
(HOWL)
RA CAPITAL MANAGEMENT, L.P.
— 10% Owner
May 8, 2026
Sale
Shares
351,514
Price
$0.71
Total Value
$249.57K
Shares Held After
5,885,968
% of Holdings
5.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
May 8, 2026
Sale
Shares
600
Price
$79.28
Total Value
$47.57K
Shares Held After
105,212
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
May 8, 2026
Sale
Shares
200
Price
$78.00
Total Value
$15.60K
Shares Held After
105,812
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
May 8, 2026
Sale
Shares
1,900
Price
$79.31
Total Value
$150.69K
Shares Held After
105,212
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Boulding Mark Elliott
— EXEC. VP AND CLO
May 8, 2026
Sale
Shares
840
Price
$78.23
Total Value
$65.71K
Shares Held After
107,112
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
uniQure N.V.
(QURE)
Abi-Saab Walid
— Chief Medical Officer
May 8, 2026
Sale
Shares
20,000
Price
$25.00
Total Value
$500.00K
Shares Held After
169,669
% of Holdings
10.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
uniQure N.V.
(QURE)
Abi-Saab Walid
— Chief Medical Officer
May 8, 2026
Sale
Shares
25,000
Price
$25.10
Total Value
$627.50K
Shares Held After
189,669
% of Holdings
11.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BIO-TECHNE Corp
(TECH)
Herr Amy E.
— Director
May 8, 2026
Sale
Shares
6,636
Price
$48.28
Total Value
$320.39K
Shares Held After
200
% of Holdings
97.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Axogen, Inc.
(AXGN)
Wendell Amy McBride
— Director
May 8, 2026
Sale
Shares
1,647
Price
$42.60
Total Value
$70.16K
Shares Held After
93,826
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Twist Bioscience Corp
(TWST)
WERNER ROBERT F.
— Chief Accounting Officer
May 8, 2026
Sale
Shares
4,961
Price
$56.88
Total Value
$282.19K
Shares Held After
49,674
% of Holdings
9.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InfuSystem Holdings, Inc
(INFU)
GENDRON PAUL ANDREW
— Director
May 8, 2026
Purchase
Shares
5,000
Price
$8.88
Total Value
$44.40K
Shares Held After
70,000
% of Holdings
7.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InfuSystem Holdings, Inc
(INFU)
Lachance Carrie
— Director
May 8, 2026
Purchase
Shares
2,000
Price
$8.83
Total Value
$17.66K
Shares Held After
237,123
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InfuSystem Holdings, Inc
(INFU)
Steele Barry G
— Executive VP and CFO
May 8, 2026
Purchase
Shares
7,000
Price
$8.71
Total Value
$60.95K
Shares Held After
96,590
% of Holdings
7.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Kroeger Christopher A.
— Director
May 8, 2026
Sale
Shares
3,205
Price
$29.20
Total Value
$93.59K
Shares Held After
1,526,309
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Kroeger Christopher A.
— Director
May 8, 2026
Sale
Shares
1,582
Price
$28.56
Total Value
$45.18K
Shares Held After
1,529,514
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Kroeger Christopher A.
— Director
May 8, 2026
Sale
Shares
29,624
Price
$27.48
Total Value
$814.07K
Shares Held After
1,531,096
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Protagonist Therapeutics, Inc
(PTGX)
Giraudo Bryan
— Director
May 8, 2026
Sale
Shares
5,130
Price
$100.00
Total Value
$513.00K
Shares Held After
12,695
% of Holdings
28.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Protagonist Therapeutics, Inc
(PTGX)
Giraudo Bryan
— Director
May 8, 2026
Sale
Shares
6,000
Price
$100.00
Total Value
$600.00K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GE HealthCare Technologies Inc.
(GEHC)
Yang Watkin Phoebe L.
— Director
May 8, 2026
Purchase
Shares
1,000
Price
$63.01
Total Value
$63.01K
Shares Held After
13,702
% of Holdings
7.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LEMAITRE VASCULAR INC
(LMAT)
LeMaitre George W
— Director
May 8, 2026
Sale
Shares
27,881
Price
$108.69
Total Value
$3.03M
Shares Held After
1,430,019
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sionna Therapeutics, Inc.
(SION)
ORBIMED ADVISORS LLC
— Director
May 8, 2026
Sale
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alphatec Holdings, Inc.
(ATEC)
Valentine Keith
— Director
May 8, 2026
Purchase
Shares
43,847
Price
$7.54
Total Value
$330.61K
Shares Held After
197,271
% of Holdings
22.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sionna Therapeutics, Inc.
(SION)
Thompson Peter A.
— Director
May 8, 2026
Sale
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Inspire Medical Systems, Inc.
(INSP)
mcCormick Shawn
— Director
May 8, 2026
Sale
Shares
696
Price
$45.31
Total Value
$31.54K
Shares Held After
27,712
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
908 Devices Inc.
(MASS)
Kenneweg John
— SVP, Sales & Product Marketing
May 8, 2026
Sale
Shares
18,255
Price
$8.11
Total Value
$148.05K
Shares Held After
57,784
% of Holdings
24.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
May 8, 2026
Sale
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
4,358,447
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
May 8, 2026
Sale
Shares
5,076
Price
$67.35
Total Value
$341.85K
Shares Held After
4,359,397
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
May 8, 2026
Sale
Shares
13,974
Price
$66.65
Total Value
$931.37K
Shares Held After
4,364,473
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
May 8, 2026
Sale
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
555,686
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
May 8, 2026
Sale
Shares
5,077
Price
$67.35
Total Value
$341.91K
Shares Held After
556,636
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
May 8, 2026
Sale
Shares
13,973
Price
$66.65
Total Value
$931.31K
Shares Held After
561,713
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CVS HEALTH Corp
(CVS)
Mandadi Tilak
— EVP, Chief Exp & Tech Officer
May 8, 2026
Sale
Shares
69,551
Price
$89.58
Total Value
$6.23M
Shares Held After
10,133
% of Holdings
87.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
Soteropoulos Paula
— Director
May 8, 2026
Sale
Shares
599
Price
$85.47
Total Value
$51.20K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Third Rock Ventures V, L.P.
— 10% Owner
May 8, 2026
Sale
Shares
5,018
Price
$40.31
Total Value
$202.26K
Shares Held After
6,432,715
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Concentra Group Holdings Parent, Inc.
(CON)
ORTENZIO ROBERT A
— Director
May 8, 2026
Sale
Shares
130,000
Price
$25.00
Total Value
$3.25M
Shares Held After
893,455
% of Holdings
12.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 801–850 of 1902 transactions (page 17 of 39)
Version: v26.5.2